Pharmacology & Drug Development Congress
  • Follow

Accepted Abstracts

Experimental and Therapeutic Trials of Amygdalin

Ragga H Salama, Abd El Rahman G Ramadan*, Tasneem A Alsanory, Mohammed O Herdan, Omnia M Fathallah, Aya A Alsanory
Assiut University, Egypt


Citation: Ramadan AER, Salama RH, Alsanory TA, Herdan MO, Fathallah OM et al  (2020) Experimental and Therapeutic Trials of Amygdalin. SciTech Central Pharma 2020. Mauritius

Received: December 01, 2019         Accepted: December 02, 2019         Published: December 02, 2019

Abstract

Natural substances and alternative medications such as amygdalin gained huge popularity in treating various diseases due to wide availability and relatively low cost. Nevertheless, their use may cause serious side effects unless appropriate doses are considered. Therefore, this review illustrates the purported anticancer activity of amygdalin as well as its other effects on different body systems. For instance, the endocrine, urinary, genital and respiratory systems, considering its toxic side effects. Also, this review mentions a variety of clinical trials using amygdalin on both, humans and animals.
 
Keywords: Amygdalin, Vitamin B17, Cyanogenic Toxicity, Antitumor, Beta-glucuronidase, Rhodanese